A transcriptional network underlies susceptibility to kidney disease progression

Area of Science:

• Nephrology
• Molecular Biology
• Genetics

Background:

• Chronic kidney diseases (CKD) molecular networks remain poorly understood.
• Previous research linked renal lesion susceptibility to a mouse chromosome 6 locus and epidermal growth factor receptor (EGFR) activation.

Purpose of the Study:

• To identify novel molecular players and pathways involved in CKD progression.
• To investigate the role of microphthalmia-associated transcription factor A (MITF-A) in modulating renal disease.

Main Methods:

• Sequence analysis to identify genetic variations in MITF-A.
• Molecular pathway dissection involving transcription factors and signaling ligands.
• Gene inactivation studies (Tgfa) in a mouse model of CKD.
• Analysis of TFE3/MITF-A ratios in human kidney disease patients.

Main Results:

• A strain-specific mutation in the 5' UTR of MITF-A reduces its protein synthesis in susceptible mice.
• MITF-A represses TGF-α transcription by interacting with histone deacetylases and antagonizes TFE3.
• Tgfa gene inactivation protected mice from renal deterioration, confirming the pathway's role.
• Increased TFE3/MITF-A ratio observed in human CKD patients.

Conclusions:

• MITF-A is a critical modifier of CKD progression through a novel transcriptional network involving EGFR signaling.
• The identified TFE3/MITF-A regulatory axis represents a potential prognostic biomarker and therapeutic target for human CKD.